-
Články
- Vzdělávání
- Časopisy
Top články
Nové číslo
- Témata
- Kongresy
- Videa
- Podcasty
Nové podcasty
Reklama- Kariéra
Doporučené pozice
Reklama- Praxe
Pandemic preparedness and responses: WHO to turn to in a crisis?
Authors: aff001
Authors place of work: Public Library of Science, San Francisco, California, United States of America and Cambridge, United Kingdom aff001
Published in the journal: Pandemic preparedness and responses: WHO to turn to in a crisis?. PLoS Med 17(5): e32767. doi:10.1371/journal.pmed.1003167
Category: Editorial
doi: https://doi.org/10.1371/journal.pmed.1003167Summary
The PLOS Medicine editors discuss the role of the World Health Organization in pandemic responses.
Keywords:
Health economics – Economics – Public and occupational health – Political aspects of health – Epidemiology – Global health – Economic impact analysis – Psychological attitudes
In the thick of a global pandemic, it should be straightforward to appreciate the role and responsibilities of the World Health Organization (WHO). With a newly emerged coronavirus, SARS-CoV-2, exerting an appalling global toll in terms of lives lost, ill-health, and societal and economic disruption, the organization is a fulcrum on which all efforts to combat the COVID-19 outbreak and manage its consequences must be based. As of April 30, in excess of 3.2 million cases had been recorded, with more than 227,000 deaths attributed to the disease [1]. WHO Director-General Tedros Adhanom Ghebreyesus, who has led the agency since 2017, has been prominent in the response to the coronavirus outbreak, not least in his authoritative public appearances. Yet the rapidity of the pandemic’s growth, and the diverse and apparently tentative responses in certain countries, have created concerns in some quarters about the agency’s capabilities to advise on and respond to disease outbreaks. Indeed, on April 14, a short suspension of US funding for WHO was announced, prompted by alleged suppression of information about the COVID-19 outbreak during its early stages in China [2]. Little is certain about the course and possible conclusion of the current outbreak, save that the actions and attributes of WHO, its structures, and its people will be scrutinized in the minutest possible detail.
WHO is tasked with forcefully representing international resolutions, creating confidence in its unparalleled technical capacity, and acting fairly and responsibly to promote health and wellbeing in all countries, as far as is possible. These countries vary enormously in population size and structure, wealth, political objectives and many other characteristics, of course. Consequently, the element of WHO’s 1946 Constitution that posits achievement of “the enjoyment of the highest attainable state of health … [by] every human being without distinction” may—perversely given its universal appeal—be subordinated to other, more short-term, factors [3]. It is easy to imagine situations in which attaching blame to an international body might be an attractive route to political or economic advantage. WHO’s revenue was about $2.9 billion in 2018 [4], made up of assessed and voluntary contributions, the latter category often linked to specific programmes or aims by donors. Large donors and countries are therefore likely to have, or be perceived to have, influence over its actions and announcements. WHO’s physical and human footprint is also criticized from time to time, and even ardent supporters would concede that, were the agency to be designed and launched today, its Swiss headquarters, along with 6 regional fiefdoms and 150 country offices, could well be reimagined in a much more streamlined fashion.
As we discussed in an Editorial in 2016 [5], WHO’s record in previous infectious disease outbreaks has not always met with unqualified approval. The agency’s response to the 2012–2014 Ebola outbreak in West Africa, under previous Director-General Margaret Chan, was seen to have been plagued by delay and dysfunction. In the subsequent reports that investigated WHO’s perceived failings, it was noted that the organization had, for example, previously cut a substantial proportion of its emergency response capability, and “lacked the governance needed to coordinate multiple stakeholders” in the response to a disease outbreak [6]. Essentially, there was a sense that the organization had been trying to do too many things with too few resources, and making questionable strategic decisions in the process.
The recent suspension of US funding for WHO has elicited criticism from many in the health arena, including PLOS [7]. Additional political manoeuvring has followed [8], and subsequently China has trumped the announcements by pledging an additional $30 million in funding, noting that WHO had been “actively fulfilling its duties and upholding an objective, scientific and impartial stance” on the disease outbreak [9]. These opportunistic political gambits could well continue in longer campaigns seeking to acquire plaudits for perceived (but at this stage perhaps ephemeral) successes in addressing the continuing outbreak, alongside creative attribution of responsibility for early, and possibly onging, errors and omissions in country-specific pandemic responses; wilful misinformation must also be considered as a factor.
We contacted a number of commentators for their views on the emerging debate around WHO’s role in the current outbreak, and Margaret Kruk, of the Harvard T.H. Chan School of Public Health, argues that “WHO plays an indispensable role in our shared health and it is one of the few institutions that is seen as credible in countries at a time that health and science are increasingly politicized. But it is hamstrung by insufficient, strings-tied funding and a governance structure that precludes its ability to speak uncomfortable truths for fear of offending member countries. The goal of reforms should be to build a technically stronger, better funded, and more independent WHO”. Although far too early to make definitive judgments about individual country or agency actions during the current pandemic, we can anticipate a frank debate about the capabilities and actions of WHO throughout this extraordinary time. Among thoughts that come to mind are, first, that political involvement with or by WHO is regrettable, with its parent organization, the United Nations, the forum for this purpose. Second, the experiences of the current pandemic need to be put to good use to prepare WHO and countries for future disease outbreaks—how do the agency’s capabilities and infrastructure, and indeed those of country public health bodies, need to be strengthened and adapted to this end? It may be that the function of WHO needs to be refocused on convening expertise and providing normative guidance for health goals, with a distinct entity, akin to UNAIDS, adopting responsibility for outbreak surveillance and responses. Finally, a global agency for health will remain essential, and all governments should seek to work with rather than counter to WHO as an essential partner in promoting the increasingly interconnected state of the world’s health.
Zdroje
1. Johns Hopkins Coronavirus Resource Center. COVID-19 Case Tracker (accessed 30 April 2020). https://coronavirus.jhu.edu/
2. Gearan A. Trump announcess cutoff of new funding for the World Health Organization over pandemic response. Washington Post, 15 April 2020 (accessed 30 April 2020). https://www.washingtonpost.com/politics/trump-announces-cutoff-of-new-funding-for-the-world-health-organization-over-pandemic-response/2020/04/14/f1df101e-7e9f-11ea-a3ee-13e1ae0a3571_story.html
3. WHO Constitution (accessed 26 April 2020). https://apps.who.int/gb/bd/pdf_files/BD_49th-en.pdf#page=7
4. WHO Budget (accessed 26 April 2020). https://www.who.int/about/finances-accountability/reports/A72_36-en.pdf?ua=1
5. The PLOS Medicine Editors. A Global Champion for Health—WHO’s Next? PLoS Med. 2016;13(6):e1002059. doi: 10.1371/journal.pmed.1002059 27351843
6. Gostin LO, Tomori O, Wibulpolprasert S, Jha AK, Frenk J, Moon S, et al. Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola. PLoS Med. 2016;13(5): e1002042. doi: 10.1371/journal.pmed.1002042 27195954
7. The PLOS Medicine Editors. We need to support the WHO, not stop its funding in the middle of a pandemic. Speaking of Medicine, 16 April 2020 (accessed 30 April 2020). https://blogs.plos.org/speakingofmedicine/2020/04/16/we-need-to-support-the-who-not-stop-its-funding-in-the-middle-of-a-pandemic/
8. Wintour P, Harvey F, Beaumont P. US scuppers G20 coronavirus statement on strengthening WHO. The Guardian, 20 April 2020 (accessed 30 April 2020). https://www.theguardian.com/world/2020/apr/20/us-scuppers-g20-coronavirus-statement-on-strengthening-who
9. Shih G. China pledges additional $30 million funding for World Health Organization. Washington Post, 23 April 2020 (accessed 26 April 2020). https://www.washingtonpost.com/world/asia_pacific/china-pledges-additional-30-million-funding-for-world-health-organization/2020/04/23/24f9b680-8539-11ea-81a3-9690c9881111_story.html
Článek vyšel v časopisePLOS Medicine
Nejčtenější tento týden
2020 Číslo 5- Psilocybin je v Česku od 1. ledna 2026 schválený. Co to znamená v praxi?
- Proč endometrióza vyžaduje principy precizní medicíny
- Precizní psychiatrie má svou cestovní mapu
- „Jednohubky“ z klinického výzkumu – 2026/4
- INFOGRAFIKA: Světový den boje proti rakovině... aneb jaké výzvy stojí před českou onkologií?
-
Všechny články tohoto čísla
- Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study
- Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
- National and regional prevalence of posttraumatic stress disorder in sub-Saharan Africa: A systematic review and meta-analysis
- Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts
- Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study
- Variations in use of childbirth interventions in 13 high-income countries: A multinational cross-sectional study
- Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: A population-based cohort study
- Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990–2017: A cohort study
- Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study
- Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial
- Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
- Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study
- Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data
- Spatiotemporal trends and ecological determinants in maternal mortality ratios in 2,205 Chinese counties, 2010–2013: A Bayesian modelling analysis
- The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the Rotterdam Study: A prospective cohort study
- Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials
- Health profile of adult special immigrant visa holders arriving from Iraq and Afghanistan to the United States, 2009–2017: A cross-sectional analysis
- Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States
- Sugary drink warnings: A meta-analysis of experimental studies
- Impact of macronutrient supplements on later growth of children born preterm or small for gestational age: A systematic review and meta-analysis of randomised and quasirandomised controlled trials
- HIV-related outcome disparities between transgender women living with HIV and cisgender people living with HIV served by the Health Resources and Services Administration’s Ryan White HIV/AIDS Program: A retrospective study
- Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis
- Antibody-based therapies for COVID-19: Can Europe move faster?
- Pandemic preparedness and responses: WHO to turn to in a crisis?
- PLOS Medicine
- Archiv čísel
- Aktuální číslo
- Informace o časopisu
Nejčtenější v tomto čísle- National and regional prevalence of posttraumatic stress disorder in sub-Saharan Africa: A systematic review and meta-analysis
- Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: A population-based cohort study
- Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study
- Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial
Kurzy
Zvyšte si kvalifikaci online z pohodlí domova
Autoři: prof. MUDr. Vladimír Palička, CSc., Dr.h.c., doc. MUDr. Václav Vyskočil, Ph.D., MUDr. Petr Kasalický, CSc., MUDr. Jan Rosa, Ing. Pavel Havlík, Ing. Jan Adam, Hana Hejnová, DiS., Jana Křenková
Autoři: MUDr. Irena Krčmová, CSc.
Autoři: MDDr. Eleonóra Ivančová, PhD., MHA
Autoři: prof. MUDr. Eva Kubala Havrdová, DrSc.
Všechny kurzyPřihlášení#ADS_BOTTOM_SCRIPTS#Zapomenuté hesloZadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.
- Vzdělávání